Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析

◆英語タイトル:Microbix Biosystems Inc (MBX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14878
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbix Biosystems Inc (Microbix) is a provider of biological and technology solutions for human health and wellbeing. The company’s products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix provides infectious disease antigens for chlamydiaceae, STI, measles, mumps and varicella, cytomegalovirus, dengue, hepatitis, respiratory antigens, rotavirus, rubella and toxoplasma gondii. The company also provides viral and bacterial samplesfor CAP and external quality assessment (EQA) approved proficiency testing (PT) programs. Microbix is headquartered in Mississauga, Ontario, Canada.

Microbix Biosystems Inc Key Recent Developments

Feb 12,2019: Microbix reports results for Q1 fiscal 2019
Feb 05,2019: Microbix provides quality assessment products update
Dec 24,2018: Microbix enhances quality management system
Dec 21,2018: Microbix reports results for fiscal 2018
Nov 19,2018: Microbix wins Business Award of Excellence

This comprehensive SWOT profile of Microbix Biosystems Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Microbix Biosystems Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Microbix Biosystems Inc – Key Information
Microbix Biosystems Inc – Overview
Microbix Biosystems Inc – Key Employees
Microbix Biosystems Inc – Key Employee Biographies
Microbix Biosystems Inc – Key Operational Heads
Microbix Biosystems Inc – Major Products and Services
Microbix Biosystems Inc – History
Microbix Biosystems Inc – Company Statement
Microbix Biosystems Inc – Locations And Subsidiaries
Microbix Biosystems Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Microbix Biosystems Inc – Business Description
Microbix Biosystems Inc – Corporate Strategy
Microbix Biosystems Inc – SWOT Analysis
SWOT Analysis – Overview
Microbix Biosystems Inc – Strengths
Microbix Biosystems Inc – Weaknesses
Microbix Biosystems Inc – Opportunities
Microbix Biosystems Inc – Threats
Microbix Biosystems Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Microbix Biosystems Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Microbix Biosystems Inc, Key Information
Microbix Biosystems Inc, Key Ratios
Microbix Biosystems Inc, Share Data
Microbix Biosystems Inc, Major Products and Services
Microbix Biosystems Inc, History
Microbix Biosystems Inc, Key Employees
Microbix Biosystems Inc, Key Employee Biographies
Microbix Biosystems Inc, Key Operational Heads
Microbix Biosystems Inc, Other Locations
Microbix Biosystems Inc, Subsidiaries
Microbix Biosystems Inc, Key Manufacturing facilities
Microbix Biosystems Inc, Key Competitors
Microbix Biosystems Inc, SWOT Analysis
Microbix Biosystems Inc, Ratios based on current share price
Microbix Biosystems Inc, Annual Ratios
Microbix Biosystems Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Microbix Biosystems Inc, Performance Chart
Microbix Biosystems Inc, Ratio Charts

★海外企業調査レポート[Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • RiskSense Inc:企業の戦略的SWOT分析
    RiskSense Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Nostra Terra Oil and Gas Company plc (NTOG):企業の財務・戦略的SWOT分析
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in New Mexico, Permian Basin located in West Te …
  • NCC Group plc:企業の戦略・SWOT・財務分析
    NCC Group plc - Strategy, SWOT and Corporate Finance Report Summary NCC Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • St Ives plc (SIV):企業の財務・戦略的SWOT分析
    St Ives plc (SIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kodiak Sciences Inc (KOD):製薬・医療:M&Aディール及び事業提携情報
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC is a drug development company that discovers new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes proprietary Bioconjuga …
  • Systematic A/S:企業の戦略・SWOT・財務分析
    Systematic A/S - Strategy, SWOT and Corporate Finance Report Summary Systematic A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Jakks Pacific, Inc.:企業の戦略・SWOT・財務分析
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tamedia AG:企業のM&A・事業提携・投資動向
    Tamedia AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tamedia AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Merit Medical Systems Inc (MMSI)-医療機器分野:企業M&A・提携分析
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Visa Inc:企業の戦略・SWOT・財務分析
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Appili Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral suspension antibiotic liquid reformulation …
  • IMCO Industries Ltd.:企業の戦略・SWOT・財務情報
    IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary IMCO Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southern Minnesota Municipal Power Agency:発電所・企業SWOT分析
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • Mission Pharmacal Company:企業の戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eutelsat Communications S.A. (ETL):企業の財務・戦略的SWOT分析
    Eutelsat Communications S.A. (ETL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Molecular Templates Inc (MTEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The company’s pipeline products include MT-3724, MT-4019, MT-5111, MT-5050 and MT-6868. Its lead product MT-3724, a fusion …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆